296 related articles for article (PubMed ID: 20100797)
21. Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients.
Wu JJ; Lin C; Sun L; Goldblum O; Zbrozek A; Burge R; Augustin M; Feldman SR
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):318-324. PubMed ID: 29846976
[TBL] [Abstract][Full Text] [Related]
22. Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis.
Zhang W; Bansback N; Boonen A; Young A; Singh A; Anis AH
Arthritis Res Ther; 2010; 12(5):R177. PubMed ID: 20860837
[TBL] [Abstract][Full Text] [Related]
23. Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies.
Dubreuil M; Navarro-Compán V; Boonen A; Gaffney K; Gensler LS; de la Loge C; Vaux T; Fleurinck C; Massow U; Taieb V; Mørup MF; Deodhar A; Rudwaleit M
RMD Open; 2024 Jun; 10(2):. PubMed ID: 38834351
[TBL] [Abstract][Full Text] [Related]
24. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.
Kimball AB; Yu AP; Signorovitch J; Xie J; Tsaneva M; Gupta SR; Bao Y; Mulani PM
J Am Acad Dermatol; 2012 Feb; 66(2):e67-76. PubMed ID: 21616560
[TBL] [Abstract][Full Text] [Related]
25. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
26. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness.
Haywood KL; M Garratt A; Jordan K; Dziedzic K; Dawes PT
Rheumatology (Oxford); 2002 Nov; 41(11):1295-302. PubMed ID: 12422003
[TBL] [Abstract][Full Text] [Related]
27. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
Ford JH; Ye W; Ayer DW; Mi X; Bhandari S; Buse DC; Lipton RB
J Patient Rep Outcomes; 2023 Apr; 7(1):34. PubMed ID: 37016181
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial.
Kimball AB; Bensimon AG; Guerin A; Yu AP; Wu EQ; Okun MM; Bao Y; Gupta SR; Mulani PM
Am J Clin Dermatol; 2011 Feb; 12(1):51-62. PubMed ID: 21110526
[TBL] [Abstract][Full Text] [Related]
29. A cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in Singapore.
Goh Y; Kwan YH; Leung YY; Fong W; Cheung PP
Int J Rheum Dis; 2019 Nov; 22(11):2001-2008. PubMed ID: 31576680
[TBL] [Abstract][Full Text] [Related]
30. Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.
Revicki DA; Rentz AM; Luo MP; Wong RL
Health Qual Life Outcomes; 2011 May; 9():36. PubMed ID: 21600054
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis.
Fallahi S; Jamshidi AR; Bidad K; Qorbani M; Mahmoudi M
Rheumatol Int; 2014 Jun; 34(6):803-9. PubMed ID: 24170319
[TBL] [Abstract][Full Text] [Related]
32. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial.
Louis E; Löfberg R; Reinisch W; Camez A; Yang M; Pollack PF; Chen N; Chao J; Mulani PM
J Crohns Colitis; 2013 Feb; 7(1):34-43. PubMed ID: 22480772
[TBL] [Abstract][Full Text] [Related]
33. Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis.
Kimel M; Revicki D; Rao S; Fryback D; Feeny D; Harnam N; Thompson C; Cifaldi M
Clin Exp Rheumatol; 2011; 29(4):624-32. PubMed ID: 21813060
[TBL] [Abstract][Full Text] [Related]
34. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
[TBL] [Abstract][Full Text] [Related]
35. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.
Duruöz MT; Doward L; Turan Y; Cerrahoglu L; Yurtkuran M; Calis M; Tas N; Ozgocmen S; Yoleri O; Durmaz B; Oncel S; Tuncer T; Sendur O; Birtane M; Tuzun F; Bingol U; Kirnap M; Celik Erturk G; Ardicoglu O; Memis A; Atamaz F; Kizil R; Kacar C; Gurer G; Uzunca K; Sari H
Rheumatol Int; 2013 Nov; 33(11):2717-22. PubMed ID: 23765201
[TBL] [Abstract][Full Text] [Related]
36. The effect of Pulmonary Rehabilitation Programme on work productivity and clinical parameters in patients with ankylosing spondylitis.
Akaltun MS; Altindag O; Gur A
Int J Clin Pract; 2021 Aug; 75(8):e14279. PubMed ID: 33914378
[TBL] [Abstract][Full Text] [Related]
37. Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work.
Boonen A; Boone C; Albert A; Mielants H
Rheumatology (Oxford); 2018 May; 57(5):791-797. PubMed ID: 29373701
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
39. Translation into Brazilian Portuguese, cross-cultural adaptation and validation of the Stanford presenteeism scale-6 and work instability scale for ankylosing spondylitis.
Frauendorf R; de Medeiros Pinheiro M; Ciconelli RM
Clin Rheumatol; 2014 Dec; 33(12):1751-7. PubMed ID: 24221505
[TBL] [Abstract][Full Text] [Related]
40. Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross-sectional study.
Yao Y; Jørgensen AR; Thomsen SF
Int J Dermatol; 2020 Mar; 59(3):333-340. PubMed ID: 31736064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
